Maximum quantity allowed is 999
Please select the quantity
CAS RN: 91421-42-0 | Product Number: N0822
9-Nitrocamptothecin

Purity: >98.0%(HPLC)
Synonyms:
- Rubitecan
Product Documents:
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | N0822 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__0H__1__5N__3O__6 = 393.36 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container ![]() |
100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 91421-42-0 |
Reaxys Registry Number | 5365063 |
PubChem Substance ID | 87560509 |
Merck Index (14) | 8288 |
MDL Number | MFCD06656294 |
Specifications
Appearance | White to Yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Specific rotation [a]20/D | +36.0 to +42.0 deg(C=0.4, CHCl3:MeOH=8:2) |
Properties (reference)
Melting Point | 268 °C |
Specific Rotation | 39° (C=0.4,CHCl3:MeOH=8:2) |
GHS
Related Laws:
Transport Information:
H.S.code* | 2939.79-000 |
Application
水不溶性のトポイソメラーゼ I阻害剤,9-ニトロカンプトテシン (9-NC)
9-Nitrocamptothecin (9-NC) is a water insoluble derivative of camptothecin [C1495] with broad antitumor activity. Its metabolite is 9-aminocamptothecin [A2063]. Camptotecin and its derivatives interfere with DNA synthesis by inhibiting the enzyme topoisomerase-I. In order to prevent and correct of topological problems caused by the DNA double helix, topoisomerase-I catalyzes the relaxation of negatively supercoiled DNA, the knotting and unknotting DNA and the linking complementary rings of single-stranded DNA into double-stranded rings. Then the inhibition action induces breaks in single strand DNA. Eventually, this leads to double-strand DNA breaks and apoptosis or cell death.
References
- Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity
- Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin
- Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice
- Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics
- The camptothecins (a review)
- Determination of 9-nitrocamptothecin and its metabolite 9-aminocamptothecin in human plasma using high- performance liquid chromatography with ultraviolet and fluorescence detection
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.